CTSO

Cytosorbents Corporation

Price

$0.34

return (12m)

-63.41%

p/e

-1.28

p/bv

-31.10

DIVIDEND YIELD

0.00%

CTSO price

Cytosorbents

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CTSO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-3.55%

3 months

-30.27%

1 year

-63.41%

2 years

-66.11%

5 years

-96.43%

10 years

-93.17%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals CTSO

Valuation

P/E

-1.28

Sector -0.16

Industry 2.77

P/BV

-31.10

Sector 1.93

Industry 2.37

P/Revenue (PSR)

0.63

Sector 1.67

Industry 1.97

EV/EBITDA

Sector -55.30

Industry -73.25

EV/EBIT

Sector -488.87

Industry -73.47

P/EBITDA

Sector -178.48

Industry -262.99

P/EBIT

Sector -214.62

Industry -268.43

P/Total Assets

0.61

Sector 0.91

Industry 1.07

P/Net Current Assets

-1.02

Sector -24.70

Industry -5.25

P/Working Capital

-2.82

Sector -5.32

Industry 3.11

EPS

-0.29

Sector -0.79

Industry -0.61

BVPS

-0.01

Sector 3.79

Industry 4.57

Efficiency

Gross Margin

71.64%

Sector 48.28%

Industry 50.49%

EBITDA Margin

0.00%

Sector -5,407,515.68%

Industry -10.73%

EBIT Margin

0.00%

Sector -62.93%

Industry -21.31%

Operating Margin

-34.73%

Sector -23.12%

Industry -27.36%

Net Profit Margins

-48.98%

Sector -27.40%

Industry -30.91%

Asset Turnover

0.25

Sector 0.13

Industry 0.15

Profitability

ROE

2,429.33%

Sector -31.93%

Industry -27.86%

ROA

-48.00%

Sector -28.25%

Industry -27.56%

ROIC

0.00%

Sector -317.33%

Industry -57.09%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.66

Sector 1.85

Industry 1.98

Net Debt / EBITDA

Sector -42.46

Industry -72.45

Net Debt / EBIT

Sector -37.26

Industry -7.11

Net Debt / Equity

-4.12

Sector -1.04

Industry -0.12

Gross Debt / Equity

-4.12

Sector -0.72

Industry 0.10

Equity/Assets

-0.02

Sector 0.43

Industry 0.45

Liabilities/Assets

1.02

Sector 0.48

Industry 0.51

Growth

5Y Revenue CAGR

-2.93%

Sector -

Industry -

5Y Earnings CAGR

-5.80%

Sector -

Industry -

Fundamentals CTSO

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CTSO Cytosorbents Corporation	$0.34	-63.19%	0.00%	-1.28	-31.10	2,429.33%	-48.98%
ISRG Intuitive Surgical Inc.	$371.80	-21.09%	0.00%	41.88	7.23	17.26%	28.62%
ABT Abbott Laboratories	$112.42	-12.47%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$91.17	3.05%	3.09%	24.60	2.36	9.59%	13.20%
BSX Boston Scientific Corp.	$46.77	-55.83%	0.00%	17.71	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$91.75	-20.34%	0.00%	21.60	6.32	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$553.20	-13.68%	0.00%	38.78	27.41	70.67%	25.03%
RMD ResMed Inc.	$238.60	-14.30%	1.04%	22.12	5.18	23.41%	27.44%
COHR Coherent Inc.	$282.51	211.44%	0.00%	115.66	4.75	4.11%	6.85%
PHG Koninklijke Philips NV	$26.71	0.25%	3.68%	20.31	1.99	9.80%	6.30%
SYK Stryker Corp.	$327.50	-15.63%	1.06%	33.67	5.23	15.55%	14.43%
INMD InMode Ltd.	$14.84	-2.34%	0.00%	11.50	1.42	12.32%	20.69%
DXCM DexCom Inc.	$90.49	18.47%	0.00%	34.80	13.27	38.14%	20.12%
EW Edwards Lifesciences Corp.	$90.23	11.53%	0.00%	51.94	4.86	9.36%	15.41%
BDX Becton Dickinson and Company	$189.33	-0.19%	2.21%	55.38	2.14	3.86%	6.30%
ALGN Align Technology Inc.	$157.75	11.11%	0.00%	28.99	2.83	9.77%	9.99%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
IRMD iRadimed Corporation	$87.75	20.18%	1.42%	49.15	11.14	22.66%	26.71%
SNN Smith & Nephew PLC	$28.91	-19.76%	2.63%	11.09	2.41	21.74%	9.20%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CTSO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Cytosorbents

Cytosorbents Corporation

Average Investor10 user rating

4.0 (0 people)

United States

38 years

Founded: 1988

2017

Time since IPO - 9 years

380

Employees

Cytosorbents Corporation (United States) is listed on the NYSE and has a market capitalization of $23.32 million, with shareholders equity totaling $-750.00 Thousand.

The company employs approximately 380 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Cytosorbents Corporation reported $37.20 million in revenue, generating net income of $-18.22 million.

Key financial metrics include a P/E ratio of -1.28, a price-to-book (P/B) ratio of -31.10, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CTSO.

Market cap

$23.32 million

Net worth

$-750.00 Thousand

$-750,000.00

Assets

$37.96 million

$37,960,000.00

Total Shares Outstanding

63.00 million

63,000,000

Average Daily Trading Volume

$136.96 Thousand

$136,961.50

Sector

Health

Industry

Medical Supplies and Equipment

CTSO

CTSO revenue and profits

Financial Results CTSO

DRAG THE FRAME TO SEE MORE DATA

CTSO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.51 31,87% (12M)

P/E

-0.84

2.83%

ROE

-178.93%

P/BV

1.51

CI - Cigna

$279.22 --4,61% (12M)

P/E

10.77

2.20%

ROE

16.04%

P/BV

1.73

CNC - Centene

$64.37 121,66% (12M)

P/E

-6.35

0.00%

ROE

-22.56%

P/BV

1.43

HUM - Humana

$390.51 30,46% (12M)

P/E

35.82

0.92%

ROE

6.72%

P/BV

2.41

SNY - Sanofi

$44.84 --5,80% (12M)

P/E

7.43

3.87%

ROE

18.43%

P/BV

1.37

LLY - Eli Lilly

$1,169.97 60,50% (12M)

P/E

41.58

0.52%

ROE

P/BV

HCA - HCA Healthcare

$419.06 4,42% (12M)

P/E

12.08

0.70%

ROE

-244.72%

P/BV

-29.56

NVS - Novartis

$153.04 23,28% (12M)

P/E

28.21

1.96%

ROE

27.47%

P/BV

7.75